Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Metzner · SciRah

Researcher profile · Semantic Scholar

B. Metzner

Share profile

B. Metzner — researcher profile on SciRah

h-index: 47
Works: 190
Citations: 13K

Most-cited papers

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
N. Schmitz, L. Trumper, M. Ziepert, M. Nickelsen +6 more
2010Blood577 citations Open access
Semantic Scholar
Improvement of overall survival in advanced stage mantle cell lymphoma.
Annina Herrmann, E. Hoster, T. Zwingers, G. Brittinger +13 more
2009Journal of Clinical Oncology427 citations
Semantic Scholar
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
O. Hermine, E. Hoster, J. Walewski, A. Bosly +33 more
2016The Lancet356 citations
Semantic Scholar
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Carsten Müller, N. Murawski, M. Wiesen, G. Held +11 more
2012Blood250 citations Open access
Semantic Scholar
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
V. Poeschel, G. Held, M. Ziepert, M. Witzens-Harig +40 more
2019The Lancet208 citations Open access
Semantic Scholar
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.
A. Josting, H. Müller, P. Borchmann, J. Baars +15 more
2010Journal of Clinical Oncology168 citations Open access
Semantic Scholar
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C. Buske, E. Hoster, M. Dreyling, H. Eimermacher +16 more
2009Leukemia153 citations
Semantic Scholar
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
C. Kyriakou, C. Canals, A. Goldstone, D. Caballero +11 more
2008Journal of Clinical Oncology149 citations
Semantic Scholar
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
B. Böll, E. Schalk, D. Buchheidt, J. Hasenkamp +15 more
2020Annals of Hematology141 citations Open access
Semantic Scholar
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas
A. Korfel, T. Elter, E. Thiel, M. Hänel +13 more
2013Haematologica127 citations Open access
Semantic Scholar
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marr
K. Cwynarski, A. van Biezen, L. D. de Wreede, S. Stilgenbauer +11 more
2012Journal of Clinical Oncology120 citations
Semantic Scholar
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.
O. Gluz, U. Nitz, N. Harbeck, E. Ting +13 more
2008Annals of Oncology112 citations Open access
Semantic Scholar
Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.
R. Pettengell, N. Schmitz, C. Gisselbrecht, Graeme M. Smith +16 more
2013Journal of Clinical Oncology111 citations
Semantic Scholar
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
V. Jurinovic, B. Metzner, M. Pfreundschuh, N. Schmitz +8 more
2018Biology of Blood and Marrow Transplantation81 citations Open access
Semantic Scholar
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
M. Nickelsen, M. Ziepert, S. Zeynalova, B. Glass +5 more
2009Annals of Oncology76 citations Open access
Semantic Scholar
First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation
M. Wilhelm, M. Smetak, P. Reimer, E. Geissinger +6 more
2016Blood Cancer Journal68 citations Open access
Semantic Scholar
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
O. Hermine, Linmiao Jiang, J. Walewski, A. Bosly +22 more
2022Journal of Clinical Oncology52 citations
Semantic Scholar
Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20+ B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL.
M. Pfreundschuh, M. Ziepert, S. Zeynalova, E. Lengfelder +12 more
2011Journal of Clinical Oncology51 citations
Semantic Scholar
Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial).
H. Einsele, P. Liebisch, C. Langer, M. Kropff +38 more
200951 citations
Semantic Scholar
Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.
M. Pfreundschuh, N. Murawski, M. Ziepert, B. Altmann +15 more
201843 citations
Semantic Scholar
Autologous Stem Cell Transplantation and Addition of Rituximab Independently Prolong Response Duration in Advanced Stage Mantle Cell Lymphoma.
E. Hoster, B. Metzner, R. Forstpointner, M. Pfreundschuh +10 more
200943 citations
Semantic Scholar
Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as in vivo purging and to maintain remission following high-dose therapy.
R. Pettengell, N. Schmitz, C. Gisselbrecht, D. Caballero +7 more
201038 citations
Semantic Scholar
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
A. Zoellner, M. Unterhalt, S. Stilgenbauer, K. Hübel +18 more
2021The Lancet Haematology37 citations Open access
Semantic Scholar
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma.
B. Glass, M. Ziepert, M. Reiser, M. Freund +6 more
2010Annals of Oncology37 citations Open access
Semantic Scholar
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis
S. Knop, M. Engelhardt, P. Liebisch, C. Meisner +29 more
2019Leukemia36 citations Open access
Semantic Scholar
A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
N. Schmitz, Lorenz Trumper, K. Bouabdallah, M. Ziepert +37 more
2020Blood35 citations Open access
Semantic Scholar
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
H. Einsele, M. Engelhardt, C. Tapprich, Jürgen Müller +23 more
2017British Journal of Haematology35 citations
Semantic Scholar
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial
C. Straka, P. Liebisch, H. Salwender, B. Hennemann +31 more
2016Haematologica34 citations Open access
Semantic Scholar
The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial
E. Hoster, M. Unterhalt, B. Wörmann, U. Duhrsen +10 more
200833 citations
Semantic Scholar
Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.
S. Knop, P. Liebisch, H. Hebart, E. Holler +26 more
200930 citations
Semantic Scholar
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial
V. Brixner, G. Bug, P. Pohler, D. Krämer +18 more
2021Haematologica29 citations Open access
Semantic Scholar
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
F. Frontzek, M. Ziepert, M. Nickelsen, B. Altmann +17 more
2021The Lancet Haematology24 citations
Semantic Scholar
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
H. Einsele, S. Knop, M. Vogel, J. Müller +17 more
2017Leukemia24 citations
Semantic Scholar
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
L. Garderet, S. Iacobelli, L. Koster, H. Goldschmidt +19 more
2018Biology of Blood and Marrow Transplantation23 citations Open access
Semantic Scholar
Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
S. Knop, Peter Liebisch, H. Hebart, E. Holler +26 more
201422 citations
Semantic Scholar
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.
A. Zander, C. Schmoor, N. Kroger, W. Krüger +11 more
2008Annals of Oncology22 citations Open access
Semantic Scholar
Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA
V. Poeschel, G. Held, M. Ziepert, B. Altmann +21 more
2018Blood17 citations
Semantic Scholar
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.
C. Straka, M. Sandherr, H. Salwender, H. Wandt +19 more
2011Blood17 citations
Semantic Scholar
Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).
M. Pfreundschuh, N. Murawski, S. Zeynalova, V. Poeschel +9 more
200917 citations
Semantic Scholar
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study
L. Thurner, M. Ziepert, C. Berdel, C. Schmidt +43 more
2023HemaSphere15 citations Open access
Semantic Scholar
Results from two phase III studies of bortezomib (BTZ) consolidation vs observation (OBS) post-transplant in patients (pts) with newly diagnosed multiple myeloma (NDMM).
C. Straka, M. Vogel, Jürgen Müller, M. Kropff +15 more
201515 citations
Semantic Scholar
Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple
C. Straka, K. Schaefer-Eckart, B. Hertenstein, F. Bassermann +35 more
2022Blood14 citations Open access
Semantic Scholar
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group
S. Sasse, Magdalena Alram, H. Müller, L. Smardova +11 more
2016Leukemia and Lymphoma13 citations
Semantic Scholar
Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.
B. Metzner, C. Pott, T. Müller, W. Gebauer +6 more
2013Annals of Oncology13 citations Open access
Semantic Scholar
Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients
C. Straka, K. Schäfer-Eckart, F. Bassermann, B. Hertenstein +26 more
201213 citations
Semantic Scholar
Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study
D. Greenfield, N. Salooja, C. Peczynski, S. M. van der Werf +20 more
2021Bone Marrow Transplantation12 citations Open access
Semantic Scholar
DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL
R. Pettengell, R. Uddin, A. Boumendil, Stephen P. Robinson +14 more
201711 citations Open access
Semantic Scholar
German High-Grade Non-Hodgkin Lymphoma Study Group analysis of patients with T-cell lymphoma treated in studies of the Treatment and prognosis of mature T-cell and NK-cell lymphoma: an
N. Schmitz, L. Trumper, M. Ziepert, M. Nickelsen +6 more
201310 citations
Semantic Scholar
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
F. Bachmann, M. Schreder, M. Engelhardt, C. Langer +29 more
2021Cancers9 citations Open access
Semantic Scholar
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma- Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group (GLSG)
V. Jurinovic, B. Metzner, M. Pfreundschuh, N. Schmitz +7 more
20169 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Schmitz×18
Invite
N. Schmitz — researcher profile on SciRah
M. Pfreundschuh×14
Invite
M. Pfreundschuh — researcher profile on SciRah
H. Einsele×14
Invite
H. Einsele — researcher profile on SciRah
M. Dreyling×13
Invite
M. Dreyling — researcher profile on SciRah

×13

Invite

H. Wandt — researcher profile on SciRah

Invite

M. Ziepert — researcher profile on SciRah

Invite

W. Jung — researcher profile on SciRah

Invite

C. Straka — researcher profile on SciRah

Invite

S. Knop — researcher profile on SciRah

Invite

E. Hoster — researcher profile on SciRah

M. Unterhalt×9

Invite

M. Unterhalt — researcher profile on SciRah

M. Gramatzki×9

Invite

M. Gramatzki — researcher profile on SciRah